Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Year-over-year book value per share growth
Latest
229.36%
↑ 356% vs avg
Percentile
P97
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
50.28%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 229.36% |
| Q3 2025 | 2.56% |
| Q2 2025 | 5.92% |
| Q1 2025 | -33.75% |
| Q4 2024 | 79.87% |
| Q3 2024 | -154.36% |
| Q2 2024 | -981.61% |
| Q1 2024 | -92.40% |
| Q4 2023 | -53.52% |
| Q3 2023 | -23.90% |
| Q2 2023 | -19.95% |
| Q1 2023 | 54.72% |
| Q4 2022 | -12.29% |
| Q3 2022 | 87.13% |
| Q2 2022 | -35.74% |
| Q1 2022 | -22.04% |
| Q4 2021 | -20.19% |
| Q3 2021 | -21.68% |
| Q2 2021 | -21.48% |
| Q1 2021 | 83.43% |
| Q4 2020 | -16.06% |
| Q3 2020 | -19.23% |
| Q2 2020 | -14.39% |
| Q1 2020 | -13.08% |
| Q4 2019 | -9.37% |
| Q3 2019 | -6.82% |
| Q2 2019 | -7.21% |
| Q1 2019 | -7.49% |
| Q4 2018 | -7.19% |
| Q3 2018 | -78.05% |
| Q2 2018 | 81.47% |
| Q1 2018 | 2857.52% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |